Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stock To Watch Today: CETX, DEPO, GEO, SUPN

Published 01/03/2017, 11:14 PM
Updated 07/09/2023, 06:31 AM

The markets had an interesting day on Tuesday, gapping up and running, and then backing off midday, but coming on at the end of the day. It was definitely a good way to start the week and the year, with the Dow Jones 30 up over a hundred points, and the rest of the indices strong, particularly Nasdaq 100. We’re going to take a look at mostly longs, but a few shorts.

Cemtrex Inc (NASDAQ:CETX) has had a nice little move since the swing trade. It popped, pulled back, formed a wedge, exploded out of the wedge, formed a breakaway gap, and ran up. On Tuesday, it was up 67 cents, or 9%, to 8.05, on 1.9 million shares traded. My target is 8-8 1/4. It’s already up in my target zone, so I would look for some pullback consolidation. Ultimately, this could be a stock that reaches in the low teens, maybe 12 or 13.

Depomed Inc (NASDAQ:DEPO), on rumors of a takeover, popped 2.32, or 13%, to 20.34, on 6 million shares traded on Tuesday, and closed at the upper end of the range. Key resistance now lies at about 21 1/2. Watch the gap and double top. If it gets through that, look for it to be a 24 1/2-25-dollar stock. It has 9.5 days to cover .

Geo Group Inc (NYSE:GEO) extended its move and broke out, up 50 cents, or 1.39%, to 36.43, on 648,589 shares traded on Tuesday. Its volume needs to be a little bit better, but it looks like it’s making a run up towards 371/2-38 short-term, and then 40 intermediate-term. There’s 3.28 days to cover .

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Supernus Pharmaceuticals Inc (NASDAQ:SUPN) may be on the verge of coming out of a wedge. On Tuesday, it popped up through, up 70 cents, or 2.77%, to 25.95, on 365,319 shares traded. If it can get the volume up to about 400,000, this stock could be a 32-34-dollar stock.

Stocks on the long side included Aerie Pharmaceuticals, Inc. (AERI), Cymabay Therapeu (NASDAQ:CBAY), Cemtrex Inc. (CETX), Ceragon Networks Ltd. (CRNT), Depomed, Inc. (DEPO), VelocityShares 3x Inverse Natural Gas linked to S&P GSCI Natural Gas Excess Return (NYSE:DGAZ), The GEO Group, Inc. (GEO), Direxion Daily Junior Gold Miners Bull 3X Shares (NYSE:JNUG), Direxion Daily Gold Miners Bull 3X ETF (NUGT), Supernus Pharmaceuticals, Inc. (SUPN), Valero Energy Corporation (NYSE:VLO), and Zynerba Pharmaceuticals, Inc. (ZYNE).

On the short side, stocks included Ambarella Inc (NASDAQ:AMBA) and DexCom Inc (NASDAQ:DXCM)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.